Interview with Howard Sui, Managing Director, Merck Serono China
As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key growth driver of the…
Address: Room 1502-1505 Tower B, Global Trade Center, N.36 East, Third Ring North Road, Dongcheng District, Beijing 100013,China
Tel: +86 10 5825 6060
Web: http://www.kendlewits.com.cn/
As the first international CRO to enter China, KendleWits has conducted more than 200 studies in China since 1997. Currently, they provide a strategic base of operations in Beijing, China, with highly qualified, dedicated CRAs, all extensively trained in compliance with ICH GCP standards. All the clinical monitoring staff holds a medical and/or pharmacy degree. With the advantage of broad patient population, accelerated patient recruitment, high trial quality and reasonable costs, KendleWits provides a strong presence as a leading CRO in China; offering full service Phase I – IV clinical trials.
clinical trials
As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key growth driver of the…
MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps…
Could you please give a brief introduction to the ABO and its history? ABO was established in 2005. The CRO business emerged in 2000 in China, and provided services for…
SinoGenoMax was founded in 1998 with the purpose of participating in the Human Genome Project. Could you give us an overview of the company’s activities since then and the transformation…
You have a long experience in the Chinese pharmaceutical market, and in particular you saw it evolve tremendously over the last 10 years. From a management perspective, would you say…
We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves” – that of all people with diabetes, 50% of diagnosed, and of those…
You completed your higher education in the US and worked there for a period afterwards; what caused you to move back to China and start this company? A lot of…
Liam Condon, Managing Director of Bayer Healthcare China discusses the government’s recent announcements regarding its much-anticipated healthcare reform plan, the future benefits of investing in rural healthcare, and the company’s…
In the last decade the medical device sector has undergone a lot of change; China has become a net importer to a net exporter of these devices. What is your…
Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine that breaking into this…
You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia Pacific. Are you still closely…
BioSino has experienced many changes since it was first established and has taken on many different forms and functions. Can you provide a brief history of the company and the…
See our Cookie Privacy Policy Here
